结直肠癌的生物标志物概况:当前的发现和未来的前景
Seyed Hamid Hoseini1, Parisa Enayati2, Majid Nazari3,4
1Department of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Journal of gastrointestinal cancer
|January 3, 2024
概括
多omics数据揭示了结直肠癌 (CRC) 中隐藏的分子驱动因素. 这种方法可以识别生物标志物并预测治疗反应,为个性化CRC管理铺平道路.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 奥米克技术的进步为癌症的分子基础提供了深刻的见解.
- 结肠直肠癌 (CRC) 的发展和进展是由复杂的分子变化驱动的.
研究的目的:
- 探索结直肠癌 (CRC) 隐藏的分子驱动因素.
- 突出OMICS方法在CRC中临床翻译的潜力.
- 确定新型生物标志物和个性化治疗策略,用于CRC.
主要方法:
- 审查最近使用多种omics方法 (基因组学,转录组学,蛋白质组学,表观组学,代谢组学) 的研究.
- 使用计算算法集成多omics数据.
- 对复杂的生物数据集进行分析,以揭示CRC机制.
主要成果:
- 多主题数据集成在CRC中揭示了新的途径和机制.
- 识别潜在的生物标志物用于CRC预后,诊断和治疗.
- 基于分子概况,预测患者对特定疗法的反应.
- 计算工具对于破译复杂的omics数据集至关重要.
结论:
- 确定生物标志物的验证对于临床应用至关重要.
- 将omics的发现转化为临床实践将推动个性化的CRC管理.
- 未来的研究应该专注于将omics数据无整合到患者护理中.
更多相关视频
相关概念视频
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:30Serum Laboratory Studies, Stool Test, Breath Test
348
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
348